The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Amidfar, Meysam | - |
dc.contributor.author | Oliveira, Jade de | - |
dc.contributor.author | Kucharska, Ewa | - |
dc.contributor.author | Budni, Josiane | - |
dc.contributor.author | Kim, Yong-Ku | - |
dc.date.accessioned | 2021-08-30T14:03:45Z | - |
dc.date.available | 2021-08-30T14:03:45Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-09-15 | - |
dc.identifier.issn | 0024-3205 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/53149 | - |
dc.description.abstract | Alzheimer's disease (AD) is the most common form of dementia worldwide. beta-amyloid peptide (A beta) is currently assumed to be the main cause of synaptic dysfunction and cognitive impairments in AD, but the molecular signaling pathways underlying its neurotoxic consequences have not yet been completely explored. Additional investigations regarding these pathways will contribute to development of new therapeutic targets. In context, developing evidence suggest that A beta decreases brain-derived neurotrophic factor (BDNF) mostly by lowering phosphorylated cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) protein. In fact, it has been observed that brain or serum levels of BDNF appear to be beneficial markers for cognitive condition. In addition, the participation of transcription mediated by CREB has been widely analyzed in the memory process and AD development. Designing pharmacologic or genetic therapeutic approaches based on the targeting of CREB-BDNF signaling could be a promising treatment potential for AD. In this review, we summarize data demonstrating the role of CREB-BDNF signaling pathway in cognitive status and mediation of A beta toxicity in AD. Finally, we also focus on the developing intervention methods for improvement of cognitive decline in AD based on targeting of CREB-BDNF pathway. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | MILD COGNITIVE IMPAIRMENT | - |
dc.subject | NEUROTROPHIC FACTOR BDNF | - |
dc.subject | LONG-TERM POTENTIATION | - |
dc.subject | CHRONIC PSYCHOSOCIAL STRESS | - |
dc.subject | ELEMENT-BINDING PROTEIN | - |
dc.subject | ADENYLYL-CYCLASE ACTIVITY | - |
dc.subject | FACTOR MESSENGER-RNA | - |
dc.subject | AMYLOID-BETA LEVELS | - |
dc.subject | LATE-LIFE ANXIETY | - |
dc.subject | MEMORY IMPAIRMENT | - |
dc.title | The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Yong-Ku | - |
dc.identifier.doi | 10.1016/j.lfs.2020.118020 | - |
dc.identifier.scopusid | 2-s2.0-85088099176 | - |
dc.identifier.wosid | 000568711600002 | - |
dc.identifier.bibliographicCitation | LIFE SCIENCES, v.257 | - |
dc.relation.isPartOf | LIFE SCIENCES | - |
dc.citation.title | LIFE SCIENCES | - |
dc.citation.volume | 257 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | MILD COGNITIVE IMPAIRMENT | - |
dc.subject.keywordPlus | NEUROTROPHIC FACTOR BDNF | - |
dc.subject.keywordPlus | LONG-TERM POTENTIATION | - |
dc.subject.keywordPlus | CHRONIC PSYCHOSOCIAL STRESS | - |
dc.subject.keywordPlus | ELEMENT-BINDING PROTEIN | - |
dc.subject.keywordPlus | ADENYLYL-CYCLASE ACTIVITY | - |
dc.subject.keywordPlus | FACTOR MESSENGER-RNA | - |
dc.subject.keywordPlus | AMYLOID-BETA LEVELS | - |
dc.subject.keywordPlus | LATE-LIFE ANXIETY | - |
dc.subject.keywordPlus | MEMORY IMPAIRMENT | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | CREB | - |
dc.subject.keywordAuthor | BDNF | - |
dc.subject.keywordAuthor | A beta toxicity | - |
dc.subject.keywordAuthor | Cognition | - |
dc.subject.keywordAuthor | Memory | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.